Rehabilitation therapies after botulinum toxin-a injection to manage limb spasticity:A systematic review

Physical Therapy

Volumn 94, Issue 11, 2014, Pages 1569-1581

  Kinnear, Bianca Z ^a   Lannin, Natasha A ^b   Cusick, Anne ^a   Harvey, Lisa A ^c   Rawicki, Barry ^d  

^a UNIVERSITY OF WOLLONGONG   (Australia)

^b LA TROBE UNIVERSITY   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT;

ADULT; AGED; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; MUSCLE SPASTICITY; PHYSIOTHERAPY; PROCEDURES; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BOTULINUM TOXINS, TYPE A; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE SPASTICITY; NEUROMUSCULAR AGENTS; PHYSICAL THERAPY MODALITIES;

EID: 84908408873     PISSN: 00319023     EISSN: 15386724     Source Type: Journal    
DOI: 10.2522/ptj.20130408     Document Type: Article

References (32)

1. Lance JW. Symposium synopsis. In: Feldman RG, Young RR, Koella WP, eds. Spasticity: Disordered Motor Control. Miami, FL: Symposia Specialists; 1980:485.
2. Sheean G, Lannin N, Turner-Stokes L, et al; Cerebral Palsy Institute. Botulinum toxin assessment, intervention and after care for upper limb hypertonicity in adults: international consensus statement. Eur J Neurol. 2010;17:74–93.
3. Yelnik AP, Colle FM, Bonan IV, Vicaut E. Treatment of shoulder pain in spastic hemiplegia by reducing spasticity of the subscapular muscle: a randomised, double blind, placebo controlled study of botulinum toxin A. J Neurol Neurosurg Psychiatry. 2007;78:845–848.
4. Cardoso E, Rodrigues B, Lucena R, et al. Botulinum toxin type A for the treatment of the upper limb spasticity after stroke: a meta-analysis. Arq Neuropsiquiatr. 2005; 63:30–33.
5. Bhakta BB, Cozens JA, Chamberlain MA, Bamford JM. Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial. J Neurol Neurosurg Psychiatry. 2000;69:217–221.
6. Chin TY, Graham HK. Botulinum toxin A in the management of upper limb spasticity in cerebral palsy. Hand Clin. 2005;19: 591–600.
7. National Stroke Foundation. Clinical guidelines for stroke management. 2010. Available at: http://www.strokefounda tion.com.au/clinical-guidelines. Accessed August 4, 2013.
8. Simpson DM, Gracies JM, Graham HK, et al; Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2008;70:1691–1698.
9. Hagedorn R. Foundations for Practice in Occupational Therapy. 2nd ed. New York, NY: Churchill Livingstone Inc; 2009.
10. Hesse S, Brandi-Hesse B, Bardeleben A, et al. Botulinum toxin A treatment of adult upper and lower limb spasticity. Drugs Aging. 2001;18:255–262.
11. Kinnear B, Lannin N, Cusick A. The promise and potential of botulinum toxin-A: national survey of therapy practices. Int J Stroke. 2011;6(suppl 1):17.
12. Hoare B, Imms C. Upper-limb injections of botulinum toxin-A in children with cerebral palsy: a critical review of the literature and clinical implications for occupational therapists. Am J Occup Ther. 2004;58: 389–397.
13. Sun SF, Hsu CW, Sun HP, et al. Combined botulinum toxin type A with modified constraint-induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabil Neural Repair. 2010;24:34–41.
14. Caty GD, Detrembleur C, Bleyenheuft C, et al. Effect of simultaneous botulinum toxin injections into several muscles on impairment, activity, participation, and quality of life among stroke patients presenting with a stiff knee gait. Stroke. 2008; 39:2803–2808.
15. Karadag-Saygi E, Cubukcu-Aydoseli K, Kablan N, Ofluoqlu D. The role of kinesiotaping combined with botulinum toxin to reduce plantar flexors spasticity after stroke. Top Stroke Rehabil. 2010;17:318–322.
16. Kinnear BZ. Physical therapies as an adjunct to Botulinum toxin-A injection of the upper or lower limb in adults following neurological impairment. Syst Rev. 2012;1:29.
17. Review Manager (RevMan) 5.0. Copenhagen, Denmark: The Nordic Cochrane Centre, The Cochrane Collaboration; 2008.
18. Higgins JPT, Altman DG. Assessing risk of bias in included studies. In: Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. New York, NY: John Wiley & Sons Inc; 2008:187–242.
19. Maher CG, Sherrington C, Herbert RD, et al. Reliability of the PEDro scale for rating quality of randomized controlled trials. Phys Ther. 2003;83:713–715.
20. Schu¨nemann HJ, Jaeschke R, Cook DJ, et al; ATS Documents Development and Implementation Committee. An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med. 2006;174: 605–614.
21. Schultz KF, Chalmers I, Hayes RJ, Aitman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273:408–412.
22. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in metaanalyses. BMJ. 2003;327:557–560.
23. Higgins JP, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. The Cochrane Collaboration. Updated March 2011. Available at: http://www.cochrane-handbook.org. Accessed February 2, 2012.
24. Diserens K, Ruegg D, Kleiser R, et al. Effect of repetitive arm cycling following botulinum toxin injection for poststroke spasticity: evidence from fMRI. Neurorehabil Neural Repair. 2010;24:753–762.
25. Farina S, Migliorini C, Gandolfi M, et al. Combined effects of botulinum toxin and casting treatments on lower limb spasticity after stroke. Funct Neurol. 2008;23:87–91.
26. Hesse S, Jahnke MT, Leucke D, Mauritz KH. Short-term electrical stimulation enhances the effectiveness of botulinum toxin in the treatment of lower limb spasticity in hemiparetic patients. Neurosci Lett. 1995;201:37–40.
27. Hesse S, Reiter F, Konrad M, Jahnke MT. Botulinum toxin type A and short-term electrical stimulation in the treatment of upper limb flexor spasticity after stroke: a randomized, double-blind, placebocontrolled trial. Clin Rehabil. 1998;12: 381–388.
28. Lai JM, Francisco GE, Willis FB. Dynamic splinting after treatment with botulinum toxin type-A: a randomized controlled pilot study. Adv Ther. 2009;26:241–248.
29. Levy CE, Giuffrida C, Richards L, et al. Botulinum toxin A, evidence-based exercise therapy, and constraint-induced movement therapy for upper-limb hemiparesis attributable to stroke: a preliminary study. Am J Phys Med Rehabil. 2007;86:696–706.
30. Reiter F, Danni M, Lagalla G, et al. Low dose botulinum toxin with ankle taping for the treatment of spastic equinovarus foot after stroke. Arch Phys Med Rehabil. 1998;79:532–535.
31. Weber DJ, Skidmore ER, Niyonkuru C, et al. Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to OnabotulinumtoxinA and task practice therapy: a single-blinded, randomized controlled pilot study. Arch Phys Med Rehabil. 2010;91:679–686.
32. Giovannelli M, Borriello G, Castri P, et al. Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis. Clin Rehabil. 2007;21:331–337.